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This article demonstrates that a simple chemical model system,
built by using a modular approach, may be used to predict the
spatiotemporal dynamics of initiation of blood clotting in the
complex network of hemostasis. Microfluidics was used to create
in vitro environments that expose both the complex network and
the model system to surfaces patterned with patches presenting
clotting stimuli. Both systems displayed a threshold response, with
clotting initiating only on isolated patches larger than a threshold
size. The magnitude of the threshold patch size for both systems
was described by the Damko¨hler number, measuring competition
of reaction and diffusion. Reaction produces activators at the
patch, and diffusion removes activators from the patch. The chem-
ical model made additional predictions that were validated exper-
imentally with human blood plasma. These experiments show that
blood can be exposed to significant amounts of clot-inducing
stimuli, such as tissue factor, without initiating clotting. Overall,
these results demonstrate that such chemical model systems,
implemented with microfluidics, may be used to predict spatio-
temporal dynamics of complex biochemical networks.
complexity  microfluidics  networks  tissue factor  nonlinear
Complex networks of interacting reactions are responsible forthe function and self-regulation of biological systems and are
the focus of a substantial research effort (1–8). The spatiotem-
poral dynamics of such networks (2, 4) is especially challenging
and interesting to understand, and to reproduce in synthetic
model systems (2, 3, 5, 9–11). Simplified physical or chemical
model systems are attractive for understanding biological com-
plexity because these models can be made simple to probe,
analyze, and understand. These models, even if correct, may be
met with skepticism that ‘‘there is no model simpler than life
itself’’ (12), unless predictions can be made with the model
system and can be tested and validated with the complex
network. This testing is often difficult for experimental models
of spatiotemporal dynamics because both the model system and
the complex network must be perturbed and observed in space
and time in a controlled fashion.
In this article, we use soft lithography and microfluidics (13) to
control and compare the spatiotemporal dynamics of two networks:
the complex network of hemostasis and a simple chemical model
system that describes the network.Ourmain question is whether the
qualitative dynamics of the complex network may be predicted by
observing the dynamics of this ‘‘analogue’’ model system, and
whether semiquantitative scaling predictions can be made to relate
the dynamics of the two systems. To control clotting, the network
of80 reactions (14) of hemostasis must be robust: it must initiate
blood clotting at a patch of substantial vascular injury but not at
patches of smaller damage that are believed to be present through-
out the vascular system (15, 16). Although most of the individual
reactions in hemostasis have been characterized, its overall spatio-
temporal dynamics remains less understood (17) because the
system is complex. The function of hemostasis has been postulated
to depend on the delicate balance of production, consumption, and
transport—by diffusion or by convective flow—of clotting factors
(14, 15, 17–19). Modeling all reactions together with transport
phenomena is exceptionally challenging. As is typical for complex
networks,manymodels are proposed to describe hemostasis but are
not readily accepted (12). Even the most basic aspects of threshold
dynamics of hemostasis remain under debate, such as whether
blood can be exposed to clot-inducing stimuli, including tissue
factor, without initiating clotting (20, 21, 46). In this article, we use
microfluidics to expose the two networks to surfaces patternedwith
patches presenting clotting stimuli. We perform this comparison of
the spatiotemporal dynamics of initiation in these two networks in
the absence of convective transport (fluid flow) tomake the analysis
unambiguous and to avoid complicating effects such as eddies and
turbulent flow present at high values of the Reynolds number (22).
To model the spatiotemporal dynamics of initiation, we sim-
plified the complexity of the hemostasis network so both reac-
tions and transport could be analyzed intuitively.We represented
(18) 80 reactions of hemostasis as three interacting modules
(5), with the overall kinetics corresponding to (i) higher-order
autocatalytic production of activators, (ii) linear consumption of
activators, and (iii) formation of the clot at high concentrations
of activators. Concentration of activators, C, acted as a control
parameter. Interactions among these modules lead to a threshold
concentration, Cthresh, above (but not below) which clotting was
initiated. In this representation, hemostasis is normally in the
stable steady state at low C. Small increases of C preserve C 
Cthresh, such perturbations decay, and the system returns to the
stable steady state. Large perturbations increase the concentra-
tion above the unstable steady state (C  Cthresh), resulting in
amplification of activators and initiation of clotting. This repre-
sentation does not require knowledge of all of the reactions of
clotting, but it is consistent with the known kinetics of hemostasis
(e.g., autocatalytic loops are involved in activation of clotting).
Here, we did not attempt to map all reactions of hemostasis onto
modules. We hypothesized that a functional, but drastically
simplified, chemical model of hemostasis may be created by
replacing each module with at least one chemical reaction with
kinetics matching that of the module. We previously used
organic and inorganic reactions (23) to create such a system and
to model spreading of clotting through junctions of vessels (18).
This system used acid (the hydronium ion H3O) as the activator
of gelling, or ‘‘clotting.’’ The clotting reaction was monitored by
observing the transition of the reaction mixture from basic to
acidic, which caused gelling of alginic acid and changed the color
of a pH indicator. Here, we directly compare the spatiotemporal
dynamics of the model system and the complex network, testing
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whether the chemical model can successfully reproduce and
predict the dynamics of initiation of clotting.
Results
Initiation of Clotting in the Chemical Model Showed a Threshold
Response to Patch Size.To observe the qualitative dynamics of this
chemical model system, we tested whether initiation of clotting
on acidic patches was robust (initiating on large but not small
patches) (Fig. 1A). UV light was used as a stimulus for initiating
clotting. Photochemical production of acid (24) was spatially
confined to patches by using a photomask and acid diffused from
the surface patch into the solution. The clotting reaction was
initiated only if the local concentration of acid exceeded the
threshold value Cthresh. Initiation of clotting in the chemical
model showed a threshold response to patch size, p [m], the
diameter of a circular patch (Fig. 1B, 17 experiments). Single
patches p  400  ptr m reliably initiated clotting in 22 s,
whereas single patches p 200 ptr m did not cause initiation
within 500 s. Control experiments (see the supporting informa-
tion, which is published on the PNAS web site) verified that
initiation was due to the production of acid at the surface and not
due to heating of the sample or photochemistry of the solution.
Initiation of Clotting in the Chemical Model May Be Described by the
Damko¨hler Number. To obtain a semiquantitative description of
the dynamics in this system, we estimated the threshold patch
size, ptr [m] (size p of the smallest patch that initiates clotting),
by considering the competition of reaction and diffusion. Re-
action produces an activator at the patch on the time scale tR [s],
and diffusive transport removes the activator from the patch on
the time scale tD [s]. For patches p  ptr diffusion dominates (tD
 tR), and the concentration of activator never reaches the
threshold Cthresh. For patches p  ptr, reaction dominates (tD 
tR), local concentration of activator exceeds the threshold Cthresh,
and clotting is initiated. This competition is described by the
Damko¨hler number (22), where ptr corresponds to p at which tR
 tD (Fig. 1C). Since tD  p2D, ptr should scale as ptr  (D 
tR)1/2, where D [m2s1] is the diffusion coefficient of the
activator. This scaling prediction is reasonable and is consistent
with the one originally proposed for membrane patch size
regulating a proteolytic feedback loop on a membrane during
Fig. 1. Human blood plasma and the simple chemical model both initiate clotting with a threshold response to the size of patches presenting clotting stimuli.
(A) Simplified schematic of a microfluidic device used to test threshold response in initiation of clotting in the chemical model. The reaction mixture was kept
over a photoacid surface containing 2-nitrobenzaldehyde. UV irradiation through a photomask photoisomerized 2-nitrobenzaldehyde (not acidic) to 2-nitroso-
benzoic acid (acidic, pKa 4), creating acidic patches of clotting stimuli (green).When clottingwas initiated, the basic reactionmixture becameacidic and turned
yellow (see the supporting information). (B) Time-lapse fluorescentmicrographs of initiation of clotting (false-colored yellow) in the chemical model on patches
p  200 m (Upper, no initiation) and p  800 m (Lower, rapid initiation). (C) Numerical simulations qualitatively describing the competition between
production of clotting activators at the patch (red) and diffusion of activators away from the patch in regulating initiation of clotting (see the supporting
information). For subthreshold patches (Upper, 50m)diffusion dominates and the concentration of activators never reaches the threshold concentrationCthresh
(dashed line) necessary to initiate clotting. For above-threshold patches (Lower, 100 m), the production of activators dominates, exceeding Cthresh, leading to
rapidamplificationofactivators and initiationof clotting. (D) Schematic of an in vitromicrofluidic systemused to containbloodplasmaand toexpose it topatches
presenting clotting stimuli. Patches of negatively charged phospholipid bilayers with reconstituted tissue factor (lipidTF; red fluorescence) were patterned in
a background of inert lipids. Blue represents clotting. (E) Time-lapse fluorescent micrographs of initiation of clotting (blue fluorescence) of blood plasma on red
patches p  50 m (Upper, no initiation) and p  100 m (Lower, rapid initiation), where p [m] is the diameter of the patch.
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clotting (15). For the chemical model system, experimental value
200  ptr  400 m agreed with predicted ptr  470 m,
calculated by using D(H)  108 m2s1 and tR  22 s.
The Chemical Model Correctly Predicts the Spatiotemporal Dynamics
for in Vitro Initiation of Clotting.This chemical model makes four
predictions for initiation of blood clotting. First, it predicts the
existence and the value of the threshold patch size, ptr. To test
this prediction and to probe the dynamics of initiation of the
hemostasis network, we developed an in vitro microfluidic
system to control initiation of clotting in space and time (Fig.
1D). We used patterned supported phospholipid bilayers (25, 26)
to present patches of the clotting stimulus, a lipid surface
containing phosphatidylserine with reconstituted human tissue
factor (TF) (27, 28). TF was incorporated into bilayers as
previously described (27, 28). TF is an integral membrane
protein that is exposed at sites of vascular damage and athero-
sclerotic plaque rupture (15, 16). These clot-inducing patches
were surrounded by background areas of inert lipid bilayers
(phosphatidylcholine). We used a microfluidic chamber to con-
tain freshly recalcified plasma over the patterned lipid surface
and to eliminate convection. Initiation in the hemostasis network
may occur through two pathways: the TF pathway and the factor
XII pathway. Corn trypsin inhibitor was used to inhibit the factor
XII pathway (29) in experiments testing initiation by TF.We and
others (27) refer to ‘‘initiation’’ in this network as the clotting
process that culminates in a spike of thrombin and the onset of
fibrin formation. We used bright-field microscopy to detect
formation of fibrin and fluorescence microscopy to detect
thrombin-induced cleavage of a peptide-modified coumarin
dye (29).
Initiation of clotting of blood plasma in this microfluidic
system displayed a threshold response to patch size. Patches p
100 m initiated clotting in 3 min (40 of 44 experiments),
whereas patches p  50 m did not initiate clotting (28 of 28
experiments; at least 30 patches per experiment) (Fig. 1E).
Background clotting was observed in 32–75 min in experiments
with patches p  50 (generally initiating not on the patches),
consistent with the 45–70 min range for initiation on surfaces
that had no patches at all and with the background clotting times
reported by others (29). Initiated clotting spread as a reactive
front at 25–35 mmin. To predict the value of ptr, we used D 
5  1011 m2s1 [approximate value for thrombin (30) as a
representative activating protein involved in the amplification of
the clotting cascade] and tR  30 	 5 s (obtained by measuring
the initiation time of clotting on a nonpatterned clot-inducing
bilayer). Predicted ptr  40 m agreed with the measurement
50  ptr  100 m. A considerably smaller threshold patch size
(few micrometers) was previously proposed by considering dif-
fusion of an activator in a membrane (15). Our results indicate
that ptr is determined by diffusion of a protein in solution.
Second, the model predicts that the size of individual patches
(isolated, noninteracting), rather than their total surface area,
determines initiation of clotting. To demonstrate this effect, we
Fig. 2. Chemical model correctly predicts that in vitro initiation of clotting in human blood plasma depends on the spatial distribution, rather than the total
surface area of a lipid surface presenting TF, a clotting stimulus. (A) Time-lapse fluorescent micrographs of initiation of clotting (yellow) in the chemical model
on arrays of patches, p 50, 200, 400, and 800 m (top to bottom, green). All arrays had the same total surface area of patches (5 105 m2). Clotting did not
initiate on arrays of patches p  50–200 m but rapidly initiated on patches p  400–800 m. (B) Graph quantifying the threshold response for initiation of
clotting in the chemical model, using data as shown inA. (C) Time-lapse fluorescent micrographs showing initiation of clotting (blue) of blood plasma on arrays
p 100 m and p 400 m patches (red), but no initiation on arrays of p 25 m and p 50 m patches (red). The total surface area of patches in all arrays
was the same (3.5 106 m2). (D) Graph quantifying the threshold response for initiation of clotting of blood plasma using data as shown in C. Clot times were
determined by monitoring the appearance of fibrin.






exposed the chemical model to arrays of patches (Fig. 2 A and
B). Each array had the same total surface area of patches (5 
105 m2) and produced the same amount of acid, but only arrays
with individual patches p 400 m initiated clotting. Total area
was irrelevant: a single patch above the threshold size quickly
initiated clotting, whereas an array of subthreshold patches with
a total surface area four times larger and producing approxi-
mately four times more acid did not (see the supporting infor-
mation). Clotting of blood plasma (Fig. 2C andD) also displayed
this dynamics: among arrays of patches of the same total surface
area, only arrays with patches p  100 m initiated clotting (six
measurements per patch size). Initiation of clotting was exquis-
itely sensitive to the spatial distribution of TF in the sample.
Knowing the amount of TF in the sample was not sufficient to
predict whether initiation would occur; in our experiments with
constant volumes of blood plasma, above-threshold patches
induced clotting, whereas an array of subthreshold patches with
a total surface area 20 times larger, bearing 20 times more TF,
did not.
Third, the model predicts that a sufficiently tight cluster of
subthreshold patches should initiate clotting (Fig. 3). Production
of the activator on patches at the perimeter of the cluster reduces
the diffusive flux of the activators away from the central patch.
For a given tR, initiation of clotting should occur for subthreshold
patches spaced closer than the diffusion length scale, equal to ptr.
To demonstrate this effect, we exposed the chemical model
(200  ptr  400) to two clusters of subthreshold patches (Fig.
3A). Clusters of 200-m patches separated by 200 m rapidly
initiated clotting, whereas clusters separated by 800 m did not.
Numerical simulations agreed with these experiments (see the
supporting information). We verified these predictions with
blood plasma (50  ptr  100), where clusters of 50-m patches
separated by 50 m rapidly initiated clotting and clusters of 50
m patches separated by 200 m did not (nine experiments)
(Fig. 3B). It is known that amplification of activators could
happen much more rapidly on the surfaces of membranes,
especially of platelets (31), and these results further confirm the
importance of transport in solution in setting ptr.
Fourth, if this chemical model represents the overall dynamics
of initiation in the network, rather than a subset of reactions in
the TF pathway, it suggests that initiation of blood clotting via
the factor XII pathway would also show a threshold response. To
initiate this pathway, we exposed blood plasma to negatively
charged glass, and initiation occurred in tR 9 min. We used the
diffusion coefficient for thrombin to predict the threshold patch
size ptr  (D  tR)1/2  160 m. To test this prediction, we
created patches of hydrophilic glass in a background of inert,
hydrophobic silanized glass (32). We rapidly determined ptr 
100 m by placing blood plasma on a single array of patches of
different sizes (Fig. 4). In all 14 experiments, patches p 200 m
induced clotting, but patches p 50 m did not. Patches p 100
m were close to threshold size, initiating clotting (12–19 min)
in only 4 of 14 experiments, consistent with either slight varia-
tions of the surface chemistry from patch to patch or the
stochastic nature (29) of the initiation of clotting via the factor
XII pathway. These experiments indicate that the ability of a
patient’s blood to initiate clotting by either the TF or factor XII
pathways can be rapidly evaluated by measuring the threshold
response on a single slide with an array of patches of different
sizes (e.g., Fig. 4).
Discussion
We focused on comparing the dynamics of initiation of clotting
in a chemical model system and the complex biochemical
network under in vitro conditions carefully controlled with
microfluidics. We described experiments performed on flat
surfaces in the absence of fluid flow. The effect of curvature of
the surfaces should be important for patches in small capillaries,
and further experiments and 3D simulations are needed to
understand this effect. Nevertheless, this work was stimulated by,
relies on, and agrees with the extensive body of work on
hemostasis (14, 15, 17, 19–21, 27–31). There are two reasons
these results may have in vivo relevance. (i) Simple in vitro
experiments (e.g., prothrombin time and activated partial throm-
boplastin time clotting tests) are routinely used in healthcare to
Fig. 3. Chemicalmodel correctly predicts that initiation of clotting of human
blood plasma can occur on tight clusters of subthreshold patches that com-
municatebydiffusion. (A) Fixed-time (54 s)fluorescentmicrographsof clusters
of subthreshold patches p  200 m (green) in the chemical model system.
These patches initiated clotting (yellow) when separated by 200 m (Right)
but not 800 m (Left). (B) Fixed-time (9 min) fluorescent micrographs of
clusters of subthreshold patches p 50 m (red) exposed to blood plasma. In
agreement with the prediction (see text for details), these patches initiated
clotting (blue) when separated by 50 m (Right) but not 200 m (Left).
Fig. 4. Chemical model correctly predicts initiation of clotting via the factor XII pathway, suggesting that themodel describes the dynamics of initiation of the
entire complex network of hemostasis in vitro. Tests of initiation of clotting via the factor XII pathway in human blood plasma on glass is shown. Two time-lapse
fluorescent micrographs at 13 (A) and 21 (B) min showing initiation of clotting (blue) on an array of clot-inducing hydrophilic glass patches p  400, 200, 100,
50, and 25 m (left to right, white) patterned in a background of inert silanized glass (black). For the blood plasma sample shown here, the threshold patch size
was between 100 and 200 m.
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evaluate the function of a patient’s clotting network and to
monitor adequacy of anticoagulation therapy. (ii)We performed
a number of additional preliminary experiments that mimic the
in vivo system more closely and observed that the predictions of
the chemical model still hold, at least under the specific condi-
tions we have tested. These preliminary experiments included
the incorporation of thrombomodulin (an integral membrane
protein that inhibits clotting) into the inert bilayer, replacing
normal pooled plasma (low platelet count) with platelet-rich
plasma and whole blood, measurements at 37°C, and varying the
TF concentration by a factor of 20. Preliminary results also
indicated that enhanced removal of activator from the patch by
convective flow, or changes in patch shape, increased ptr. These
preliminary experiments, although outside of the scope this
article, must be used along with in vivo investigations (33) to
establish the importance of this work to the function of hemo-
stasis in the human body. If these results are relevant in vivo, they
provide a potential resolution to the debate (20, 21, 46) on
whether TF can circulate in blood without causing clotting. In the
absence of damage, TF could circulate on individual micropar-
ticles that are below the threshold ‘‘patch’’ size. Recruitment and
localization of TF-bearing microparticles to surfaces could con-
struct a large patch that exceeds threshold and initiates clotting.
The mechanism proposed here for blood clotting might also be
relevant to other ‘‘all-or-none’’ systems that are initiated by
surface-bound stimuli, such as T cell activation (34).
Here, we have tested whether spatiotemporal dynamics of a
complex reaction network can be modeled by (i) separating the
network into modules, (ii) building an experimental chemical
network by replacing each module with a simple chemical
reaction, and (iii) using microfluidics to probe (4) the dynamics
of the chemical model and the biological network under similar
conditions in space and time. Surprisingly, the simple chemical
model was semiquantitatively predictive for initiation of blood
clotting in vitro. Chemists have used simple mechanisms and
synthetic model systems to understand reactivity of organic
molecules (35) and function of enzymes (36–40). Chemical
models have stimulated our understanding of spatiotemporal
dynamics of a diverse range of nonequilibrium systems, including
catalysis (41), oscillations in chemistry (3) and biology (42),
oocyte development (1), and fibrillation in myocardium (43).
Recently, several hundred molecular dimensions representing
the complex apoptosis network have been correlated by math-
ematical data analysis to two fundamental dimensions describing
most of the dynamics (44). Substantial evidence that biology is
modular (1, 5, 6, 44, 45) provides additional motivation to test the
generality of this approach to understand spatiotemporal dy-
namics of hemostasis and other complex reaction networks.
Materials and Methods
See the supporting information for detailed procedures and
additional control experiments.
Preparing the Reagents of the Chemical Model. Two precursor
solutions were prepared and combined in equal portions to form
the metastable model reaction mixture (23). The two precursor
solutions were (i) an aqueous solution containing Na2S2O3
(0.492 mmol), alginic acid (5.8 mgml), and bromophenol blue
(0.425 mM) (pH 7) and (ii) an aqueous solution containing
NaClO2 (2.99 mmol) (pH 10.7). Initiation of clotting in the
chemical model consisted of Na2S2O3 and NaClO2 reacting to
form a significant amount of H, which caused gelling of alginic
acid and the transition of bromophenol blue to yellow, accom-
panied by quenching of red fluorescence. The photoacid-coated
substrate was prepared by spin coating a 20- to 30-m-thick layer
of a dispersion of 2-nitrobenzaldehyde (50% by weight) in
dimethylsiloxane-ethylene oxide block copolymer onto a sili-
conized coverslip. The microfluidic chamber used for the chem-
ical model was constructed by sealing a poly(dimethylsiloxane)
gasket to a siliconized coverslip. A 30-l drop of the model
reaction mixture was placed in the chamber, and the chamber
was sealed to the photoacid substrate. A photomask allowed
patches of UV light (300–400 nm) to contact the substrate only
in specific locations, thus generating patches of acid. Epifluo-
rescence microscopy was used to monitor the reaction mixture.
Numerically Simulating the Modular Mechanism of Initiation of Clot-
ting on Surfaces Presenting Clotting Stimuli.Numerical simulations
were used solely to illustrate that a threshold patch size can exist
for the proposed modular mechanism, using a single rate equa-
tion to represent the kinetics of each module. The purpose was
not to predict the exact size of the threshold patch. We believe
that the time scale of reaction, tR, a single experimentally
determined parameter, is a simpler and more reliable predictor
of the size of the threshold patch than a simulation. To simulate
numerically the change in concentration of activator, C, we
modeled the mass transport of C with the standard convection-
diffusion equation using a commercial finite element package
FEMLAB 3.1 (Comsol, Stockholm, Sweden). We used a diffu-
sion coefficient of 5  1011 m2s1 [approximate value for a
solution-phase protease in blood clotting, such as thrombin (30)].
We considered diffusion and reactions occurring in the x,y
dimensions in solution as well as at a surface patch surrounded
by a 1-mm ‘‘inert’’ vicinity. In this pseudo-2D simulation, the z
dimension was modeled by a single layer of 1-m-thick mesh
elements (1-m boundary layer) (17). Three rate equations were
incorporated into the simulation: (i) production of C at the
surface of the patch, rate  kpatch,; (ii) autocatalytic production
of C in solution, rate  kprod[C]2  b; and (iii) linear consump-
tion of C in solution, rate  kconsum[C]. The values used were
[C]initial  1  109 M, kpatch  1  109 Ms1, kprod  2  107
M1s1, b 2 1010Ms1, and kconsum 0.2 s1. These values
were selected based on approximate values (17) for represen-
tative reactions in blood clotting.
Patterning Substrates to Test Initiation of Clotting of Blood Plasma.
Patterned substrates were prepared by using photolithography
(26, 32). Glass coverslips were extensively cleaned and then
made inert to clotting, either by forming a bilayer of phosphati-
dylcholine or a monolayer of hydrophobic silanes. In experi-
ments testing the initiation of clotting through the TF pathway,
a bilayer containing 1,2-dipalmitoyl-sn-glycero-3-phosphocho-
line (DPPC) with 3 mol % Oregon green 1,2-dihexadecanoyl-
sn-glycero-3-phosphoethanolamine (Oregon green DHPE) was
formed. In experiments testing initiation through the factor XII
pathway, a monolayer of n-octadecyltrichlorosilane (OTS) was
formed. The inert substrates were placed under a photomask
(chrome on quartz) and irradiated with deep UV light. In
experiments testing initiation via the TF pathway, the patterned
DPPC bilayers were backfilled with TF-reconstituted vesicles
(28) containing 1,2-dilauroyl-sn-glycero-3-phosphocholine
(DLPC) (79.5 mol %), L--phosphatidylserine from porcine
brain (PS) (20 mol %), Texas red 1,2-dihexadecanoyl-sn-glycero-
3-phosphoethanolamine (Texas red DHPE) (0.5 mol %), and TF
(TF:lipid ratio of 2.5 107). Assuming that all TF incorporated
into vesicles, the calculated surface concentration was 0.08
fmolcm2. For the patterned silanized substrates, hydrophilic
regions were detected by a wetting test using glycerol.
Measuring Initiation of Clotting of Blood Plasma on Patterned Sub-
strates. The microfluidic chambers used to contain blood plasma
over the patterned substrates were constructed primarily from
poly(dimethylsiloxane) fabricated from multilevel, machine-
milled, brass masters. Pooled normal plasma (human) was
purchased from George King Bio-Medical (Overland Park, KS).
Platelet-rich plasma and whole-blood samples were obtained






from individual healthy donors in accordance with the guidelines
set by the Institutional Review Board (Protocol No. 12502A) of
University of Chicago. In experiments testing initiation via TF
pathway, corn trypsin inhibitor was added to the plasma (100
gml) to inhibit the factor XII pathway (29). Citrated blood
plasma was recalcified and immediately placed on top of the
substrate in the microfluidic chamber, and the chamber was
sealed with a siliconized coverslip. Bright-field microscopy was
used to detect the formation of fibrin, and fluorescence micros-
copy was used to detect thrombin-induced cleavage of a peptide-
modified coumarin dye (29) (see the supporting information).
The clot times reported here indicate the time that fibrin
appeared, and in all experiments fibrin formation and increased
fluorescence were correlated.
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